200
Participants
Start Date
June 28, 2019
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2025
Cardiostat
This is a prospective observational study including patients accepted by the heart team for a TAVI procedure. There will be no restriction regarding the type of valve and approach used for the TAVI procedure. Following the TAVI procedure, the patients will be under telemetry until hospital discharge and, at hospital discharge, they will be monitorized up to 4 more weeks using the CardioSTAT® device.
IUCPQ, Québec
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
OTHER